Tiziana Life Sciences Ltd.

Biotechnology • Healthcare • London, United Kingdom • TLSA (NCM)

Tiziana Life Sciences Ltd, a biotechnology company, engages in the development of transformative therapies for neurodegenerative and lung diseases in the United States. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for use in the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It is also developing TZLS-501, a fully human mAb targeting the IL-6 receptor for use in the treatment of inflammatory and oncology indications. Tiziana Life Sciences Ltd was incorporated in 1998 and is headquartered in London, the United Kingdom.

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Tiziana Life Sciences (NASDAQ:TLSA) Trading Up 7.4% - Still a Buy? - MarketBeat

MarketBeat • Jan 3

Tiziana Life Sciences Leads A Trio Of Promising Penny Stocks - Yahoo Finance

Yahoo Finance • Sep 22

Tiziana Life Sciences Rings the Closing Bell - Nasdaq

Nasdaq • Dec 17

Tiziana Life Sciences to Dose First Patient in Phase 2 Alzheimer’s Trial - Stock Titan

Stock Titan • Dec 12

Tiziana Life Sciences to Dose First Patient in Phase 2 Alzheimer's Trial - Investing News Network

Investing News Network • Dec 12

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Tiziana Life Sciences Ltd had layoffs?

No layoff events have been recorded for Tiziana Life Sciences Ltd in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Tiziana Life Sciences Ltd have?

Tiziana Life Sciences Ltd has approximately 9 employees.

What industry is Tiziana Life Sciences Ltd in?

Tiziana Life Sciences Ltd operates in the Biotechnology industry, within the Healthcare sector.

Is Tiziana Life Sciences Ltd a publicly traded company?

Yes, Tiziana Life Sciences Ltd is publicly traded under the ticker symbol TLSA on the NCM. The company has a market capitalization of approximately $0.18 billion.

Where is Tiziana Life Sciences Ltd headquartered?

Tiziana Life Sciences Ltd is headquartered in London, United Kingdom.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.